Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Aeon Biopharma, Announces Marc Forth Is Stepping Down As President And CEO, Effective April 4, 2025. The Board Has Appointed Jost Fischer To Serve As Interim CEO

Author: Benzinga Newsdesk | March 27, 2025 04:08pm

Posted In: AEON